SCHEMBL6987846

SCHEMBL6987846

COc1ccc2onc(OCCNC(=O)OC(C)(C)C)c2c1C

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
KCNH2 Q12809 1/20 0.39
ATM Q13315 2/20 0.38
DRD2 P14416 5/20 0.38
SCN9A Q15858 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A43 Q9HB55 1/20 0.37
BRD4 O60885 2/20 0.36
IDO1 P14902 1/20 0.36
PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6992284 0.89 CA12 (0.44) CA12CA1CA2CA9SCN9A
SCHEMBL6988124 0.86 SCN9A (0.43) CA12CA1CA2CA9KCNH2
SCHEMBL6988489 0.86 CA12 (0.42) CA12CA1CA2CA9SCN9A
SCHEMBL6994606 0.86 CA12 (0.42) CA12CA1CA2CA9SCN9A
SCHEMBL6991252 0.86 CA12 (0.44) CA12CA1CA2CA9SCN9A
SCHEMBL6990613 0.81 CA12 (0.46) CA12CA1CA2CA9SCN9A
SCHEMBL6988405 0.80 CA12 (0.44) CA12CA1CA2CA9SCN9A
SCHEMBL6988469 0.80 LMNA (0.45) CA12CA1CA2CA9ATM
SCHEMBL6993977 0.80 CA12 (0.46) CA12CA1CA2CA9CYP1A1
SCHEMBL6988146 0.80 CA12 (0.40) CA12CA1CA2CA9KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed